Pharmacological approaches to reducing allogeneic blood exposure.

Pharmacological approaches to reducing allogeneic blood exposure.

Item
http://www.wikidata.org/entity/Q35050993
'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective.What is the evidence for using hemostatic agents in surgery?Aprotinin and major orthopedic surgeryAn overview of blood-sparing techniques used in spine surgery during the perioperative period.Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions.Management of bleeding emergencies: when to use recombinant activated factor VII.Surgical management in treatment of Jehovah's witness in trauma surgery in Indian subcontinent.Point of care testing in children undergoing cardiopulmonary bypass.A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
P2860

Pharmacological approaches to reducing allogeneic blood exposure.

Item
http://www.wikidata.org/entity/Q35050993
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacological approaches to reducing allogeneic blood exposure.
@ast
Pharmacological approaches to reducing allogeneic blood exposure.
@en
type
label
Pharmacological approaches to reducing allogeneic blood exposure.
@ast
Pharmacological approaches to reducing allogeneic blood exposure.
@en
prefLabel
Pharmacological approaches to reducing allogeneic blood exposure.
@ast
Pharmacological approaches to reducing allogeneic blood exposure.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Pharmacological approaches to reducing allogeneic blood exposure.
@en
P2093
P2860
P304
P31
P356
10.1046/J.1423-0410.2003.00258.X
P433
P478
P577
P698